BIOCHINA 2026 | March 12–14 | Suzhou, China

BIOCHINA 2026 will convene thousands of decision-makers from Chinese and global biopharmaceutical industries, including C-level executives, business development and licensing leaders, technical and procurement specialists, distributors, commercial agents, innovators, CDMOs, and solution providers. The event offers a unique platform to explore sourcing, licensing, co-development, and market expansion opportunities in China and globally.

Exhibition access is available for only $50. Attendees will have the opportunity to visit the exhibition, meet Chinese manufacturers, distributors, and solution providers, and explore collaboration opportunities in sourcing, licensing, and joint development. The exhibition provides a direct and efficient way to connect with qualified manufacturers actively seeking international distributors and partners.

BIOCHINA 2026 offers a range of opportunities for establishing business relationships with Chinese manufacturers and distributors, exploring licensing and co-development projects, and participating in high-efficiency one-on-one meetings through BiOPartnering, which allows direct engagement with decision-makers.

For more information and registration, exhibition tickets can be purchased at https://u.morebio.cn/6bueiyE2 , and BiOPartnering one-on-one meetings can be scheduled via https://lnkd.in/guMTS2jx. For inquiries, please contact biochina@enmore.com.

BIOCHINA 2026 is the premier platform for connecting global biopharma stakeholders, discovering sourcing and licensing opportunities, and accelerating partnerships and collaborations in the Chinese market.